Cancers,
Journal Year:
2024,
Volume and Issue:
16(6), P. 1127 - 1127
Published: March 12, 2024
Background:
Vasomotor
symptoms
(VMSs)
associated
with
menopause
represent
a
significant
challenge
for
many
patients
after
cancer
treatment,
particularly
if
conventional
menopausal
hormone
therapy
(MHT)
is
contraindicated.
Methods:
The
Menopause
Cancer
(MAC)
Study
(NCT04766229)
was
single-arm
phase
II
trial
examining
the
impact
of
composite
intervention
consisting
(1)
use
non-hormonal
pharmacotherapy
to
manage
VMS,
(2)
digital
cognitive
behavioral
insomnia
(dCBT-I)
using
Sleepio
(Big
Health),
(3)
self-management
strategies
VMS
delivered
via
myPatientSpace
mobile
application
and
(4)
nomination
an
additional
support
person/partner
on
quality
life
(QoL)
in
women
moderate-to-severe
cancer.
primary
outcome
change
cancer-specific
global
QoL
assessed
by
EORTC
QLC
C-30
v3
at
6
months.
Secondary
outcomes
included
frequency
bother/interference
symptoms.
Results:
In
total,
204
(82%
previous
breast
cancer)
median
age
49
years
(range
28–66)
were
recruited.
A
total
120
completed
protocol.
Global
scores
increased
from
62.2
(95%CI
58.6–65.4)
70.4
67.1–73.8)
months
(p
<
0.001)
intention
treatment
(ITT)
cohort
(n
=
204)
62
per-protocol
(PP)
120).
At
least
50%
reductions
noticed
as
well
degree
six
prevalence
reduced
93.1%
baseline
45.2%
0.001).
Sleep
Condition
Indicator
8.5
(SEM
0.4)
17.3
0.5)
0.0005)
ITT
7.9
PP
cohort.
Conclusions:
targeted
improves
frequent
bothersome
vasomotor
benefits
frequency,
Journal of Sleep Research,
Journal Year:
2023,
Volume and Issue:
32(6)
Published: Aug. 29, 2023
Summary
Cognitive
behavioural
therapy
(CBT)
is
the
recommended
first‐line
treatment
for
insomnia.
However,
guideline
care
very
seldom
available
and
most
patients
receive
no
treatment,
or
less
effective
second‐line
pharmacotherapy
sleep
hygiene,
neither
of
which
are
evidence‐based
chronic
The
primary
challenge
CBT
has
been
supply.
There
not
enough
therapists
to
meet
enormous
demand.
We
must
accelerate
clinician
training,
but
this
approach
can
never
be
sufficient,
even
with
abbreviated,
efficient
therapies.
Fortunately,
however,
landscape
also
changed
dramatically.
Fully‐automated
digital
(dCBT)
emerged
as
a
safe,
effective,
scalable
delivery
format.
dCBT
software
only,
so
it
disseminated
readily
widely
medication.
Moreover,
integrated
into
services.
Just
medications
delivered
through
health
professionals
systems,
approved
programmes
same.
an
ecosystem
psychologically‐based
should
necessitate
medical
prescription
model.
Our
proposed
stepped
framework,
comprises
both
population
clinical
service
initiatives,
enabling
universal
access
diverse
ways
in
may
(in‐person,
face‐to‐face,
using
telehealth,
group
therapy,
digitally)
operate
congruently
efficiently
optimise
people
at
all
levels
complexity
need.
With
safe
clinically
products
now
set
become
established
treatments,
clearly
differentiated
from
wellness
apps,
there
potential
rapidly
transform
insomnia
services
and,
first
time,
deliver
international
scale.
Journal of Sleep Research,
Journal Year:
2023,
Volume and Issue:
33(2)
Published: July 5, 2023
Stroke
is
frequently
accompanied
by
long-term
sleep
disruption.
We
therefore
aimed
to
assess
the
efficacy
of
digital
cognitive
behavioural
therapy
for
insomnia
improve
after
stroke.
A
parallel
group
randomised
controlled
trial
was
conducted
remotely
in
participant's
homes/online.
Randomisation
online
with
minimisation
between-group
differences
age
and
baseline
Sleep
Condition
Indicator-8
score.
In
total,
86
community-dwelling
stroke
survivors
consented,
whom
84
completed
assessments
(39
female,
mean
5.5
years
post-stroke,
59
old),
were
or
control
(sleep
hygiene
information).
Follow-up
at
post-intervention
(mean
75
days
baseline)
8
weeks
later.
The
primary
outcome
self-reported
symptoms,
as
per
(range
0-32,
lower
numbers
indicate
more
severe
insomnia,
reliable
change
7
points)
post-intervention.
There
significant
improvements
compared
(intention-to-treat,
n
=
48,
36,
5
imputed
datasets,
effect
p
≤
0.02,
Neurorehabilitation and neural repair,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 6, 2025
Background
Our
understanding
of
sleep
during
early
stroke
care
and
its
impact
on
rehabilitation
outcomes
remains
limited.
The
objectives
this
work
were
to
(1)
evaluate
multidimensional
health
disruptions
acute
inpatient
for
individuals
with
stroke,
(2)
explore
the
relationship
between
health/disruptions
functional
recovery.
Methods
Data
from
103
analyzed
rehabilitation.
Sleep
assessed
via
patient
reports,
actigraphy,
biometric
sensors.
Functional
measured
at
admission
discharge.
Generalized
Linear
Models
(GLMs)
used
describe
changes
in
over
time,
multivariate
regressions
sleep-related
predictors
Results
Over
stays,
improved
a
23%
reduction
wake
after
onset
15%
fewer
multiple
overnight
disruptions.
GLMs
revealed
that
quality
was
associated
reduced
activity
increased
heart
rate
time.
Poor
initial
cognitive
status
more
Lastly,
minimal
associations
found
Conclusions
is
generally
poor,
though
improves
affected
by
neurological
recovery
hospital
environment.
Overnight
autonomic
biomarkers
perceived
health,
both
physiological
environmental
factors
triggered
association
indirect
indicators
requires
further
investigation.
These
findings
reveal
new
insights
about
which
can
inform
early,
targeted
interventions
optimize
post-stroke
outcomes.
SIESTA,
ClinicalTrials.gov
(NCT04254484).
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: May 16, 2025
The
metaverse,
defined
as
a
collective
virtual
shared
space
created
by
the
convergence
of
augmented
reality
(AR),
(VR),
and
Internet,
offers
new
opportunities
for
mental
healthcare
delivering
immersive
engaging
digital
therapies.
This
study
examines
current
landscape
metaverse-based
applications,
analyzing
their
effectiveness
potential
risks.
Using
systematic
literature
review
(SLR)
case
research,
four
therapeutic
applications-NightWare,
Freespira,
EndeavorRx,
Sleepio-were
evaluated
ability
to
address
conditions
such
PTSD,
anxiety,
ADHD.
results
indicate
that
therapies
can
provide
significant
benefits,
with
clinical
validation
supporting
effectiveness.
However,
concerns
around
user
privacy,
accessibility,
long-term
efficacy
remain
challenges.
Overall,
represent
promising
shift
in
healthcare,
offering
innovative,
personalized,
scalable
solutions.
Further
research
is
needed
ethical
issues,
improve
confirm
impact
these
interventions.
International Journal of Stroke,
Journal Year:
2023,
Volume and Issue:
19(5), P. 490 - 498
Published: Oct. 27, 2023
Background
and
purpose:
Sleep
disorders
are
increasingly
implicated
as
risk
factors
for
stroke,
well
a
determinant
of
stroke
outcome.
They
can
also
occur
secondary
to
the
itself.
In
this
review,
we
describe
variety
different
sleep
associated
with
analyze
their
effect
on
Methods:
A
search
term-based
literature
review
(“sleep,”
“insomnia,”
“narcolepsy,”
“restless
legs
syndrome,”
“periodic
limb
movements
during
sleep,”
“excessive
daytime
sleepiness”
AND
“stroke”
OR
“cerebrovascular”
in
PubMed;
“sleep”
ClinicalTrials.gov)
was
performed.
English
articles
from
1990
March
2023
were
considered.
Results:
Increasing
evidence
suggests
that
stroke.
addition,
disturbance
has
been
reported
half
all
sufferers;
specifically,
an
increase
is
not
only
sleep-related
breathing
but
periodic
sleep,
narcolepsy,
rapid
eye
movement
(REM)
behavior
disorder,
insomnia,
duration,
circadian
rhythm
sleep–wake
disorders.
Poststroke
worse
Conclusion:
common
consequence
Recent
guidelines
suggest
screening
after
It
possible
treatment
could
both
reduce
improve
outcome,
although
further
data
clinical
trials
required.
SLEEP,
Journal Year:
2024,
Volume and Issue:
47(8)
Published: May 25, 2024
To
investigate
the
cost-effectiveness
of
cognitive
behavioral
therapy
for
insomnia
(CBTI),
with
an
additional
focus
on
digital
CBTI
(dCBTI)
in
adults
insomnia.
We
searched
eight
electronic
databases
economic
evaluations
CBTI:
PubMed,
Scopus,
Web
Science,
psycINFO,
Cochrane,
Library,
CINAHL,
ProQuest,
and
National
Health
Service
Economic
Evaluation
Database.
Meta-analyses
were
performed
to
effects
costs
between
control
groups
(no
treatment,
other
treatments
included
hygiene
education
treatment
as
usual).
Subgroup
analyses
dCBTI
conducted.
Twelve
randomized
controlled
trial
studies
2004
2023
our
systematic
review
meta-analyses.
The
incremental
cost-utility
ratios
showed
that
more
cost-effective
than
controls,
from
healthcare
perspective
societal
perspective,
respectively.
Compared
demonstrated
significantly
better
efficacy
within
12
months.
Healthcare
higher
compared
controls
6
months
but
there
was
no
difference
at
Additionally,
associated
lower
presenteeism
Our
findings
suggest
is
or
It
may
bring
benefits
long
term,
especially
long-lasting
cost
reduction.
In
addition,
one
options
CRD42
022
383
440.
www.crd.york.ac.uk/PROSPERO.
Cost-effectiveness
(CBTI):
a
meta-analysis.
BMJ Open,
Journal Year:
2023,
Volume and Issue:
13(4), P. e071764 - e071764
Published: April 1, 2023
Consolidation
of
motor
skill
learning,
a
key
component
rehabilitation
post-stroke,
is
known
to
be
sleep
dependent.
However,
disrupted
highly
prevalent
after
stroke
and
often
associated
with
poor
recovery
quality
life.
Previous
research
has
shown
that
digital
cognitive
behavioural
therapy
(dCBT)
for
insomnia
can
effective
at
improving
stroke.
Therefore,
the
aim
this
trial
evaluate
potential
improvement
using
dCBT
programme,
improve
outcomes
We
will
conduct
parallel-arm
randomised
controlled
(Sleepio)
versus
treatment
as
usual
among
individuals
following
affecting
upper
limb.
Up
100
participants
randomly
allocated
(2:1)
into
either
intervention
(6-8
week
dCBT)
or
control
(continued
usual)
group.
The
primary
outcome
study
change
in
symptoms
pre
post
compared
usual.
Secondary
include
overnight
memory
consolidation
measures
between
groups,
correlations
changes
behaviour
group
depression
fatigue
groups.
Analysis
covariance
models
used
analyse
data
from
secondary
outcomes.
received
approval
National
Research
Ethics
Service
(22/EM/0080),
Health
Authority
(HRA)
Care
Wales
(HCRW),
IRAS
ID:
306
291.
results
disseminated
via
presentations
scientific
conferences,
peer-reviewed
publication,
public
engagement
events,
stakeholder
organisations
other
forms
media
where
appropriate.
NCT05511285.
Journal of Sleep Research,
Journal Year:
2024,
Volume and Issue:
33(2)
Published: Feb. 21, 2024
Dear
members
of
the
ESRS,
readers
JSR,
In
this
issue
we
have
a
focus
on
insomnia,
nightmares
and
mental
health.
Nevertheless,
also
other
areas
sleep
medicine
research
are
covered:
few
articles
deal
with
disordered
breathing,
neurology
is
covered,
one
article
relates
to
dreaming
animal
some
others
age,
in
children
adolescents.
Let
me
highlight
for
you:
Pahari
et
al.
(2024)
investigated
whether
reaction
time
psychomotor
vigilance
related
hypoxic
load
patients
apnea.
To
end
855
(473
males,
382
females)
suspected
OSA
who
underwent
overnight
polysomnography
task
(PVT)
were
studied.
By
means
sophisticated
analysis
it
turned
out
that
severity
intermittent
hypoxaemia
was
strongly
associated
longer
times
males
but
not
females.
On
hand
arousal
index
had
strongest
association
PVT
results
Thus,
authors
conclude
impact
impaired
seems
be
stronger
than
Fleming
studied
randomized
controlled
trial
digital
cognitive
behavioral
therapy
insomnia
might
improved
after
stroke
through
therapeutic
intervention.
The
performed
parallel
group
conducted
remotely
participants'
homes
online.
86
community-dwelling
survivors
took
part
study,
84
completed
baseline
assessments
either
or
control
condition.
Follow-ups
contacted
as
well.
Primary
outcomes
self-reported
symptoms
Sleep
Condition
Indicator.
It
there
significant
improvements
Indicator
compared
Furthermore
respect
secondary
shorter
sleep-onset
latencies
better
mood
treatment.
Cost-effectiveness
demonstrated
intervention
superior
control.
No
serious
events
occurred.
further
should
test
made
accessible
large
samples
post-stroke
order
improve
their
sleep.
Šonka
longitudinal
study
idiopathic
hypersomnia.
Sixty
diagnosed
hypersomnia
≥3
years
ago
center.
Mean
duration
follow-up
almost
10
years.
83%
reported
persistent
hypersomnia,
only
55%
no
disease
could
explain
excessive
daytime
sleepiness
prolonged
A
complete
resolution
hypersomnolence
without
stimulant
treatment
lasting
6
months
rated
17%.
So
initially
presented
change
typical
picture.
Saner
effects
restriction
(with
high-intensity
exercise)
alertness
young
healthy
males.
24
matched
into
three,
5-night
interventions:
normal
sleep,
down
less
four
hours
exercise.
average,
despite
previously
findings,
exercise
did
positive
detriments
mood,
wellness,
alertness.
Sleep Medicine,
Journal Year:
2024,
Volume and Issue:
120, P. 65 - 84
Published: May 12, 2024
Insomnia
is
highly
prevalent
in
stroke
patients;
however,
there
no
ideal
intervention.
This
systematic
review
examined
the
effect
and
safety
of
Chinese
herbal
medicine
(CHM)
acupuncture
on
sleep
adults
with
stroke.
BMJ Open,
Journal Year:
2024,
Volume and Issue:
14(2), P. e077442 - e077442
Published: Feb. 1, 2024
There
is
growing
evidence
that
sleep
disrupted
after
stroke,
with
worse
relating
to
poorer
motor
outcomes.
It
also
widely
acknowledged
consolidation
of
learning,
a
critical
component
poststroke
recovery,
sleep-dependent.
However,
whether
the
relationship
between
and
poor
outcomes
stroke
related
direct
interference
sleep-dependent
processes,
currently
unknown.
Therefore,
aim
present
study
understand
measures
mediate
clinical
post
stroke.
We
will
conduct
longitudinal
observational
up
150
participants
diagnosed
affecting
upper
limb.
Participants
be
recruited
assessed
within
7
days
their
followed
at
approximately
1
6
months.
The
primary
objective
determine
in
subacute
phase
recovery
explains
variability
limb
(over
above
predicted
potential
from
Predict
Recovery
Potential
algorithm)
this
dependent
on
learning.
test
mediates
whole-body
outcomes,
associated
specific
electrophysiological
signals
alterations
during
recovery.
This
trial
has
received
both
Health
Research
Authority,
Care
Wales
National
Ethics
Service
approval
(IRAS:
304135;
REC:
22/LO/0353).
results
help
enhance
our
understanding
role
function
disseminated
via
presentations
scientific
conferences,
peer-reviewed
publication,
public
engagement
events,
stakeholder
organisations
other
forms
media
where
appropriate.
ClinicalTrials.gov:
NCT05746260,
registered
27
February
2023.